Retin-A

Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV)

Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial

Effects of a cosmetic 'anti-ageing' product on photoaged skin

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Effects of a cosmetic 'anti-ageing' product on photoaged skin

Effects of a cosmetic 'anti-ageing' product on photoaged skin

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial

Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment

Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV)

Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV)

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV)

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV)

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV)

Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study

Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV)